Purchase Order 75F40120P00071
Award Date 2/6/20
Potential Completion Date 2/5/23
Potential Value $50K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $125,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a service agreement to provide Oxford Nanopore's GridION instruments located at the FDA's Center for Food Safety and Applied Nutrition, Office of Regulatory Science. This award is not set aside for any small business program. Oxford Nanopore has secured numerous federal contracts to...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
- This federal contract award is for the purchase of specific supplies and reagents for an Oxford Nanopore GridION instrument, awarded to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $29,162.00, is a firm fixed-price purchase order placed by the Food and Drug Administration (FDA), a civilian government agency. The award is not associated with a set-aside program and has an ultimate completion date of March 29, 2024. Oxford Nanopore...
- Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for $15,000.00 and does not have a set-aside designation. It provides for the delivery of Oxford Nanopore's GridION Standard Support, which includes their nanopore-based electronic systems for analyzing single molecules such as DNA, RNA, and proteins. This contract supports...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
- The Food and Drug Administration awarded a $116,289 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a biotechnology company specializing in nanopore-based electronic systems for genomic sequencing. The contract, awarded on September 16, 2021, with an ultimate completion date of August 24, 2027, encompasses GridION software licenses and device warranties, as well as Oltrax software licenses and device warranties. These products address limitations in traditional...
- This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...